Odyssey

Developer of immunotherapeutics for immunological and cancer diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups108 employees language odysseytx.com

Registered entities

Social engagement

Social engagement: 15.2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

31 investors on record; lead investors include General Catalyst, SR One, Orbimed, Ascenta Capital.

Investor typeCountShare
Venture capital1755%
Private equity310%
Bank & private debt310%
Other / undisclosed826%

Recent activity

12 May 2026
Milestone
regulatory
8 May 2026
Milestone
regulatory
10 Mar 2026
Leadership hire
CEO of IFM Therapeutics
Coming soon